Media

Media

filter by theme
WOMEN's HEALTH
ENDOCRINOLOGY
Cell therapy
CORPORATE
REGULATORY

May 2015

11

Historic decision grants Italian women direct access to ellaOne® oral emergency contraceptive

April 2015

17

ellaOne® Receives Prestigious Nicholas Hall & Company Award for the Most Innovative European New Product of the Year

HRA Pharma Closes Investment in Embera NeuroTherapeutics to Advance Development of Novel Therapies for Addiction

April 2015

12

HRA Pharma Closes Investment in Embera NeuroTherapeutics to Advance Development of Novel Therapies for Addiction

April 2015

10

Emergency contraceptive pill roll out across Europe brings prescription-free ellaOne® to millions of women

January 2015

13

Historic decision from the European Commission grants 120 million women direct access to ellaOne® emergency contraceptive across the European Union.

December 2014

15

Ketoconazole HRA® Granted European Marketing Authorisation as an Orphan Drug for the Treatment of Endogenous Cushing’s Syndrome

Landmark recommendation from EMA paves the way for access without prescription to the ellaOne® morning-after pill across Europe in 2015.

November 2014

21

Landmark recommendation from EMA paves the way for access without prescription to the ellaOne® morning-after pill across Europe in 2015.

HRA Pharma Acquires a Novel Ovarian Cancer Immunotherapy from Pantarhei Bioscience

October 2014

27

HRA Pharma Acquires a Novel Ovarian Cancer Immunotherapy from Pantarhei Bioscience

filter by theme
WOMEN's HEALTH
ENDOCRINOLOGY
Cell therapy
CORPORATE
REGULATORY
closeyou are leaving hra pharma
You are now leaving www.hra-pharma.com and being redirected to an external website which might not be under control of HRA Pharma.
do you want to proceed ?